BIOMIMETIC THERAPEUTICS, INC. 4
4 · BIOMIMETIC THERAPEUTICS, INC. · Filed Mar 2, 2012
Insider Transaction Report
Form 4
BULLOCK LAWRENCE E
Chief Financial Officer
Transactions
- Award
Stock Options (right to buy)
2012-02-29+80,000→ 80,000 totalExercise: $2.08From: 2013-02-28Exp: 2022-02-28→ Common Stock (80,000 underlying)
Holdings
- 28,000(indirect: By Children)
Common Stock
- 58,723
Common Stock
Footnotes (2)
- [F1]Mr. Bullock disclaims beneficial ownership of these shares except to the extent of his pecuniary interest in them.
- [F2]Stock options vest 25% each year on the anniversary of the 2/29/2012 grant date.